Kim-Fredrik Schneider, CEO of Abi Global Health, joins host Ayush Jain to explain how Abi tackles healthcare access by using scarce clinicians more efficiently rather than waiting for more of them. He puts the global gap at about 10 million doctors and 25 million nurses and argues that poaching staff between countries, or waiting 15 years to train new doctors, fixes nothing in the short term.
Kim describes three design choices that set Abi apart from traditional telemedicine: no patient app, with the service embedded in clients’ apps, websites and messaging channels; on-demand algorithmic matching that replaces the appointment; and AI inside the consultation to cut clinician time per case. He explains why post-COVID telemedicine has stopped saving payers money, and why Abi keeps a human clinician in the loop rather than building an AI doctor. The second half is a playbook for going global: launch in five countries and five languages at once, hire for international range, start with the least regulated universal service, and expand market by market. It closes with Kim’s side projects in Uganda and Tanzania.
Kim frames Abi’s work as an access and equity problem driven by an undersupply of healthcare professionals. By his count the world is missing about 10 million doctors and 25 million nurses, and he stresses that this is not only a problem for poorer countries. Moving doctors from one country to another only shifts the gap, and training a new doctor takes about 15 years. His conclusion is that the only near-term option is to use existing clinicians more effectively, which is where AI comes in: to allocate professionals to cases and to make each interaction take less of their time.
Munjal Shah of Hippocratic AI started from the same staffing gap on this show and reached a very different answer: autonomous AI agents for non-diagnostic work. Kim’s model keeps the clinician at the center.
Kim’s first point is that people don’t plan to get sick, so asking them to download a health app is a hard sell and pushes customer acquisition costs up. Abi’s answer is to be present at the moment of need: there is no patient app, and the service runs through clients’ own apps via APIs, a website widget, and messaging services from SMS and WhatsApp to Telegram, Viber, LINE and Kik. That is the same logic behind integrating with things that make life easy for users instead of asking them to adopt one more platform.
The second change removes the appointment. Algorithms match each case to the best available clinician using language and specialty rules, past performance on similar questions and predicted availability, so doctors never schedule shifts. Kim says Abi connects people to a doctor in under 30 seconds, around the clock, with median match times near 10 seconds in some markets. The third is AI inside the consultation, which Abi has done since 2016, to cut the clinician time each case takes. For teams building their own virtual care product, those are architecture decisions made early in telemedicine app development, not features added later.
Ayush pushes the point further: no one has time to log into a separate system, so health products should be built integration first. Kim agrees and describes it running in both directions. Where clients can share customer data, users arrive already known, with no sign-up. On the way out, some clients use Abi as a check-in before a specialist appointment, and the output of that interaction is carried into the rest of the patient’s medical record.
That outbound step, writing into the record a clinic already uses, is where most digital health products slow down, one EHR at a time. Mindbowser builds it as a custom integration, or teams run ConnectHealth, which connects a product to 20+ EHRs through one integration model, inside their own cloud.
Kim’s view of the post-COVID market is blunt. Traditional telemedicine replaced a 15-minute visit with a 15-minute video call, so it never touched the basic unit of cost, and the extra consultations it enabled now strain payers who expected savings. He adds that as venture capital tightened over the previous 18 months, providers with 20 to 30 percent gross margins pulled out of countries, dropped clients or went under, leaving insurers looking for alternatives. He also sees renewed interest from pharmaceutical companies in patient support programs and patient education.
On AI, he draws a firm line. Abi builds human-in-the-loop AI that supports the clinician, and patients, not vendors, should decide what they are comfortable letting AI take over. His test for any tool is behavior change: there is little evidence that people who use a symptom checker then skip the doctor, and “if you’re not changing behavior, then you’re just a toy.” Trust in a real clinician is what changes behavior, which is also the argument for designing AI in telemedicine around the care team rather than in place of it.
Kim’s advice to founders who want to expand abroad starts with structure. Abi launched in five countries and five languages at once (the UK, France, Germany, Italy and Spain), which forced every piece of technology and every operating assumption to be multinational and multilingual from the start. Small choices, such as how to label country versus language and which ISO codes to use, are painful to reverse later. He also hires for international range and chose multinational clients as a point of difference.
On regulation, he recommends starting with the most universal, lightest-touch service. For Abi that was text-based medical advice delivered by local doctors in each market, since most rules protect local doctors and Abi was not crossing borders with care. Heavier services, such as e-prescriptions that need integration with national prescribing systems, came later, market by market. That sequencing, he says, is how Abi reached 40 countries and 26 languages.
Welcome to HealthTech with Purpose podcast. Today we talk about the intersection of technology, health and strategy with the founder of Abi Global Health, Kim-Fredrik Schneider. Kim, a seasoned CEO and health technology entrepreneur, co-founded Abi Global Health in 2016 with a bold vision to make professional healthcare radically accessible for all. With over 15 years of leadership experience in high-growth tech firms across the globe, Kim’s expertise has propelled Abi Global Health to remarkable success. Under his guidance, Abi Global Health has revolutionized telehealth utilization, service innovation and customer growth worldwide. Today the company delivers on-demand healthcare to over 15 million people in 40 countries, leveraging a unique blend of real doctors, artificial intelligence (AI) and machine learning. Join us as we delve into Kim’s journey, insights and the transformative impact of Abi Global Health on global healthcare accessibility.
Hello Kim, how are you today? Welcome to HealthTech with Purpose podcast. How are things at your end of the world?
It’s great to be here. Thanks for taking the time to chat. Things are going well, in sunny Barcelona at the moment, visiting our office here. Life is good. How are you?
Very nice. Same. I think this is a good year for all of us, hopefully. That’s the wish, and we’re just striving to keep it going. But yeah, glad to be connected for today’s podcast, because some of the work that you have done is very disruptive for health. At HealthTech with Purpose we are consistently speaking with different founders who are changing the course of health, and we get to know different viewpoints. One of the things that stood out when I was speaking with you earlier is the disruption that you’re building and bringing into the telehealth space. So why don’t you explain in your own words what Abi Global Health is all about, and what kind of impact you have been able to make?
Yeah, sure. What I would say is that the big problem we’re solving is one of healthcare access and health equity, and we know that’s really a global issue with relevance for everyone in the world. One of the most intractable drivers of this inequity, and really one of the key factors stopping people from accessing healthcare, is an undersupply of healthcare professionals. The world is missing about 10 million doctors, probably about 25 million nurses, and that’s not a poor country problem. It’s a universal problem.
Right now what happens is this country steals doctors from that country, and that country steals doctors from this country, and that’s not a solution. And it takes about 15 years to make a new doctor. That’s also not a solution, not in the short term. So the only option we have today is to use the resources we have more effectively. Fundamentally, what we’re doing is deploying innovative technologies like AI to both allocate and use healthcare professional resources more efficiently. We can get more into the business model, but that’s really the basis of our approach.
We encapsulate our mission as being to make professional healthcare as easy to access as advice from a friend, and we see that as having three parts. Number one, everything we do involves healthcare professionals. Easy to access is our obsession. And advice from a friend means that we build empathy into all of our solutions as well.
Sounds like everything that we need today to fix health, so that’s awesome.
I don’t know that it’s everything, but it’s a big piece of it.
Yeah. So what led you to getting started on this idea? Tell us a bit about your background and your journey.
Sure, sure. My personal connection to healthcare started at a very young age. My best friend from the age of four was born with a genetic condition that led to a very medicalized childhood. It’s the kind of thing that has actually taken me years to really think about and get comfortable with myself. I think for all of us, whatever our childhood was like, that was normal, that was reality, and sometimes it’s not until you’re an adult that you really start to process and think about how typical that situation was. So I was around a close friend whose childhood was very medicalized, and I think that experience, and particularly losing him when we were 12, really triggered in me a deep interest in medicine. In fact, even the name of our company is inspired by his name. It’s been a real driving force for my life journey.
I initially wanted to study medicine. I couldn’t quite hack it when it came to chemistry, but it was always an area that I really insisted on working in. So I found a role as an Executive Vice President at a company called Sermo many years ago. Sermo is a global social network for doctors, and I was leading a team of about 200 people across eight offices there, selling services into the pharmaceutical industry, which was very rewarding in many ways.
But while I was there, I was looking at what was going on in the telemedicine space, and I saw a profound lack of innovation. It appeared that most telemedicine companies were basically clinics with Skype instead of a front door. They hadn’t done anything to really transform the business model or, really critically, the unit of interaction between the patient and the doctor, and the associated cost of that interaction. So to me it seemed logical to use this global network approach that we were using at Sermo, but to apply it to direct patient interactions.
I was introduced through a mutual friend to my co-founder, Dr. Victor Vicens, who is from Barcelona, although he did a residency at Mount Sinai in New York and part of his medical degree in France. He had been working for many years in the telemedicine space, after practicing medicine for many years before that. It was really a meeting of minds. He had the experience that traditional telemedicine didn’t scale, was very expensive, and people weren’t using it in those days before COVID. I came to him and said, look, on the scalability and cost side, I’ve got a radically different model for that. For me, the challenge was: what’s the business model here? He had some great answers on that side. And then together we worked on this question of why don’t people use it? What’s wrong with the traditional user interfaces? There’s a lot more to say about that, maybe we can get into it later, but we essentially looked to solve those three fundamental issues.
Another critical piece in that journey was that we wanted to make sure we had a solution that was for everyone, and I feel very strongly about this. If you’re going to be innovating in the healthcare space, you have to innovate for everybody. You have a moral imperative: if you have a solution that is actually delivering better health outcomes, that’s something you need to find a way to do globally, not just in the wealthiest countries in the world. So from the beginning we designed our service to have integrated AI, and we designed our service to work in every kind of context in the world. Both of us had a lot of experience in sub-Saharan Africa previous to founding Abi, for example, and we really insisted that it’s a service that is going to work for everybody in every context.
That’s great. So tell us, what are the major differentiators that Abi has compared to other telehealth solutions? Like you mentioned, telehealth solutions are all around, but what increases their effectiveness, according to you?
Yeah. In some respects, one of our challenges is that we did everything differently, so it’s been hard to encapsulate that in our marketing, frankly. But we can break it down in a few ways.
One is that question of why people were not using telemedicine before COVID. Everyone’s been celebrating the increase in telemedicine, but I still think the right way to put it is: what’s wrong with telemedicine that it took a global pandemic for people to start using the product? Think of all the other tech success stories out there. Imagine if it took a cataclysm to make Facebook work, or Google work.
For us, the fundamental issue with the traditional approach to user interfaces for healthcare is this. If I were to ask you how many times next month you plan to eat pizza, or take a taxi, or watch Netflix, these are all things you can imagine yourself doing. If I said, hey, download my app and you’ll get a 15% discount on all those things, you’d consider downloading the app. How many times do you plan to be sick in the next month? You see the issue. Obviously, for people living with chronic disease it’s a very different story, and I think things like an app or a full user journey are really appropriate for that, and I’m not saying they’re not appropriate in other contexts as well. But it’s a very difficult thing to engage with somebody on, because we all know we will need healthcare, but none of us plan to need it in the near future. So if you make an offer of “sign up to this program” or “download this app,” that’s very challenging. It’s a well-known issue across the space that customer acquisition costs are very, very high in healthcare, again because people don’t plan to need it.
Our view on that from the beginning was that the answer to that problem is to be there at the moment people need you, and the best way to already be there is to build models that integrate into existing user interfaces. So rather than being yet another telemedicine app, we don’t have an app now and we’ve never had an app. We have an app for our healthcare professionals, but that’s a different story. For patients, we have no downloadable app. A lot of our clients have apps, and they use our application programming interfaces (APIs) to integrate our service into their apps. They have lots of other reasons for people to download those apps, which is great, but that’s not the business we’re in. So we have an API interface that integrates into other people’s platforms, we have a widget that can integrate into a website or into an app, and we’re also integrated with every messaging service out there. The service is available through SMS, through WhatsApp, through Telegram, through Viber, which is big in some countries, through LINE, through Kik. Name an app and we’re in it. We’ve used that interface as a mechanism for delivering the service to people. I’ve often compared it to somebody knocking on your door and saying, “I’ve got a pizza for you. I’ll just stand outside, let me know when you’re hungry.” That’s kind of the model we use. So that’s one piece.
The second piece is the way we allocate physicians, or healthcare professionals generally, to a case. This is also a radical change. For as long as there’s been healthcare, there has been this appointment paradigm, to the point where people even use it as a metaphor for seeing a doctor: I have an appointment, I have a doctor’s appointment, how did your appointment go? It’s this whole idea that you need to book a time when you’re available and the doctor’s available, then cross your fingers that when you get there they’re ready for you, and the doctor’s crossing their fingers that you actually show up. There’s a whole industry just for getting people to show up to their appointments.
What we realized is that with the vast shortage of healthcare professionals, that’s not a sustainable paradigm. We have completely smashed that paradigm and moved to an on-demand approach, which is possible with algorithms. When a patient has a need, we use algorithms to match that need to the best available healthcare professional. Lots of factors are taken into account. Some of it is just hardcoded business rules, like language or specialty, but a lot of it is more subtle: what is this doctor proven to be good at answering in the past? What is their predicted availability? By using that predicted availability model, on the healthcare professional side we don’t need to schedule, we don’t need to book, we don’t need to hire, and the doctors have a zero-commitment approach on their side, which again is a radical difference for them. We figure out when they’re available; they don’t have to tell us.
What’s the net impact of that? The net impact is that we’re connecting people to a doctor in less than 30 seconds, 24 hours a day, across 40 countries. Imagine that: 40 countries, 24 hours a day, less than 30 seconds. We have markets where median match time is about 10 seconds. That is a radical shift from “make an appointment next week,” and it completely changes the availability of professionals, just that piece.
And then the last big piece, because there’s a lot of little stuff we’ve innovated on as well, but the last really big innovation is something people are just starting to talk about now, and we’ve been doing it since 2016: integrating AI into the consultation itself to reduce the amount of time the healthcare professional takes for a consultation. That’s the fundamental cost unit. Again, in the traditional telemedicine model you’re replacing a 15-minute visit with a 15-minute visit. You’re just not saving money, and it’s causing havoc across the world now that people are actually using telemedicine post-COVID. It’s unsustainable cost-wise, and it’s unsustainable from a resource perspective. We need to deliver the same or more value from that consultation, but with less physician time per case.
There are a number of ways we’ve done that. One is the way we architect the consultation itself, and then there are a lot of tools we use to support the healthcare professional during the consultation that make it much more efficient. The net result is that we’re about three to nine times more efficient than a traditional telemedicine consultation, much less a traditional face-to-face visit, with really radical implications for anyone paying for healthcare: insurance companies, pharmaceutical companies, public payers, large companies, a whole slew of people who are interested in delivering healthcare more efficiently.
Great, that’s good to have. I think you said it right: I can now see that they’re small things, but they all add up to make that big difference. Some of those things seem so subtle, which in my terminology I call magic beans. Magic beans are something people don’t realize is missing when it’s not there, but when it’s there it makes them happy. They just think something is missing but they don’t know what, and then there’s this magic bean.
I like that. We might steal that phrase internally.
Yeah. In fact, another thing I would fully agree with from my own work is that I always suggest integration first. You are pretty much echoing my thoughts that you should not be building standalone health applications. You should be building integrations, because nobody now has the time to log into a separate system, whether your users are providers or…
Exactly. Both providers and users. Integration in and integration out, both directions. I think for us that’s critical, and this point about login is absolutely right. We architect our services so that you have access to them and there’s no sign-up. Not all of our clients have adequate amounts of customer data or can share their customer data, but for the majority who do, that means you have a very smooth system where we already know who you are when you come in. And then we can send you out. We have clients, for example, who offer us as a check-in before you make an appointment with a specialist, and we’re then able to transfer what we do into the rest of their medical record. So it’s integration on the way into the service, integration on the way out, and as much as possible bringing the service to where the user is, not making the user come to you.
Right, right. Great. Moving forward, this is very interesting and a lot of learning, especially for the listeners. Until now I’ve understood that you saw and realized the doctor shortage crisis, and that led you to start building Abi. Tell us about the present state of things. COVID has come and gone, and I think in a positive sense more people are now open to using a telehealth solution for their needs. Maybe it means more competition too, I don’t know. But tell us what key differences you have seen in the last few years. What are the positive signs, and any bad signs, if you can share? How is the overall market moving along?
This episode of HealthTech with Purpose podcast is brought to you by Mindbowser, a product engineering and digital transformation company focused on health. At Mindbowser, we enable health companies to build the future of health with accessible, equitable [inaudible] patient care. We strongly believe that technology can empower a healthier world, and that’s why we are partnering with healthcare experts like you to make it happen.
Hi guys, thanks for listening to HealthTech with Purpose. Make sure to subscribe to us on Spotify, Apple and YouTube for more expert insights on industry innovation and transformation. And remember: share the knowledge.
Yeah, it’s been interesting to observe and to be part of this process. Initially there was a huge surge in telemedicine usage during COVID. We actually did some very interesting work ourselves: we were able to predict COVID waves in countries about two weeks in advance using our AI Labs natural language processing (NLP) technology to analyze…
What are your biggest markets?
Oh gosh. Basically the biggest countries, but we’re all over the world, and not always the markets you would expect. We’re big in Romania, we’re big in Switzerland, but we operate in the US, all over Asia, Eastern and Western Europe, South America, North America. We’re all over the place. And because we operate business to business (B2B), our markets are really about where our clients want us to be.
On this question of COVID, what’s been quite interesting to see is how the various healthcare payers have reacted to the surge in usage. The big promise of traditional telemedicine was that it was going to save money, and it hasn’t. So there’s actually a lot of panic among both private and public payers, insurance companies, employers and others. They’ve found, and it’s something we’ve always said, that it’s like the Emperor’s New Clothes: some people are finally realizing what was always true. If you replace a 15-minute consultation with a 15-minute consultation, surprise, surprise, you’re not saving money. It’s actually becoming quite unsustainable, because it leads to incremental consultations in many cases that weren’t happening previously. From a health perspective that’s a good thing, people should be having those consultations, but from a cost perspective it’s unsustainable, and also in terms of pressure on healthcare systems.
So there’s a real challenge among healthcare payers, particularly insurance companies. We work with most of the big insurance companies in the world, and a lot of these companies have really struggled with traditional telemedicine models and are looking for an alternative right now from a cost perspective.
The other thing that’s happened is that venture capital has been much harder to come by over the last 18 months than it was previously, and that’s had an effect. These traditional telemedicine models that don’t touch the basic unit of cost tend to have gross margins of 20 to 30%. Our model is significantly higher; we’re a much more efficient business and much less capital intensive than they were. Essentially, VC was subsidizing these inefficient telemedicine models, and when that capital started to dry up, companies have been pulling out of countries, they’ve been firing clients, and some of them are going bankrupt or have gone bankrupt. I don’t need to name names; those in the industry know who I’m talking about. That’s again a big problem for the insurance companies, the pharmaceutical companies and others who rely on these kinds of telemedicine services. But for us it’s not a surprise at all, because these models were not adequately innovative and really suffered from this fundamental issue that they didn’t change the basic unit of cost in the interaction. So in the insurance sector, that’s really what’s been going on: people are realizing that these models are not sustainable, their suppliers are not reliable, and they’re looking for alternatives.
What we’re seeing in the pharmaceutical industry, which we work with a lot, and which is a little more unusual for telemedicine companies, is a renewed interest in these kinds of services, particularly for things like patient support programs and patient education. There’s a lot of work they sponsor that involves patients interacting with healthcare professionals, where patients’ expectations are changing and more efficient models are appropriate.
Right, right. I very much echo that, because remote patient monitoring (RPM) is coming in a big way overall, and there’s a lot of push, especially in the US and in the UK as well, I believe, to keep patients from having to come to the hospital. I think that would all have the aspect of telehealth: how do you keep someone healthy, or keep monitoring them…
Well, the default response to a lot of this question of how we stop people from consuming unnecessary healthcare has, for years, been: make it harder. The NHS ran a program a few years ago which was something like five things to do before you call your doctor. They’re trying to keep people away from doctors. What’s so radical about what we’re doing at Abi is that we can actually give you more consultations, more interactions, lower the bar to access, and at the same time reduce the pressure on the system and reduce the cost. For me that’s the true promise of technology. That’s exactly what technology delivers: more for less money, not the traditional paradigm of less for less money.
Right. In fact, you would be happy to hear something I’m going to share. I was listening to a talk from Vinod Khosla, one of the big VCs, and he was mentioning that with AI he foresees a future where every person would have a personalized doctor. That’s one of the big impacts of AI he sees, and what you are building is pretty much along the same lines: how do you get access? With more and more AI aspects getting added, I believe you’ll also be part of that revolution that is going to happen.
Well, this raises a very interesting question about the role of AI versus the role of real doctors. I would imagine what he was talking about was an AI doctor. Our philosophy on that is that we really believe quite strongly in building human-in-the-loop AI, with AI in a supportive role to the healthcare professionals. Our philosophy longer term is that patients themselves will decide which aspects they’re comfortable with AI taking over, and when they want that to happen, and I think it’s really important that the patients are in charge of that.
Ultimately, what we do works because people trust what we do. They trust the doctor, they trust the answer, they trust the advice, and they change their behavior as a result. This is one of the big differences between what we’re doing and, for example, symptom checkers. There’s very little evidence that when someone uses a symptom checker, they then don’t go to a doctor. If you’re not changing behavior, then you’re just a toy. You’re not actually a tool; you’re not really useful in the healthcare system, in my view. So for us it’s very, very important to have the healthcare professional front and center, because of the trust that generates and the behavior change that generates.
Right, right. Makes sense, definitely. I think the future always surprises us, so let’s see.
One of the things, Kim, I really wanted you to expand on is the global business that you’ve built, and I’ll tell you the context. I speak with a lot of health tech founders, especially early to mid-stage, and one of the things they want to do is expand geographically outside their home country. A US company would want to go to Europe, and vice versa, or maybe to Asian markets. Since you have been there, done that, what are some of the lessons you could share if someone aspires to build their health tech company with operations globally?
Yeah, that’s a really, really interesting one. I mentioned earlier what I see as the moral imperative of delivering health innovation globally. I certainly have some advice on that, but I also have a bit of an unfair advantage, which is that I was born both American and European. I was born in San Francisco, and I was born a Swedish citizen. I spent my summers in Sweden, and then my family, for about…
A big unfair advantage.
Yeah. So I’ve always understood both those markets very well. And my family has about a 130 to 140-year history of doing business across Asia as well, so that was very much integrated into my life. My mother grew up in Japan, and I have family members who have been living in countries all over Asia for generations. So for me it felt very natural to operate internationally from the beginning.
In terms of the advice I can give, we did a few things early on that I think made a very big difference. One of them is that we launched our service in five countries. There are a lot of structural decisions you can make which, on the one hand, may make your life more difficult in the short term, but in the long term will make it easier, and for me that was one of them. By challenging ourselves to launch in five markets and five languages, the UK, France, Germany, Italy and Spain, it meant that all of the tech we used, all the infrastructure we built, and all the basic assumptions about how we operate were multinational and multilingual from the beginning. That was a very conscious decision, because we knew we wanted to go global in the end, so why not begin with the end in mind? That would be one of my recommendations: if you want to build a global business, build it global from the beginning. There are all these little things that you’ll forget if you don’t, like how you’re going to label country versus language, and which ISO codes you’re going to use. These basic architectural choices can be very, very challenging to do in reverse. If you force yourself to do it from the beginning, it’s much, much easier.
The other thing I would say is hiring. We have a very, very diverse team of people. We are always looking for people who speak more languages, or have more backgrounds, or have experience working in different countries. They don’t necessarily need to be from a place; they can have worked there or have a good knowledge of it. That’s very helpful. Even just people who are well traveled, who have a global perspective on things and understand that healthcare systems are different in different parts of the world, that people’s basic assumptions and terminology are different. All these little choices early on make it easier to scale internationally later.
And for us, we also chose to work with clients that were multinational. That was both because we could and because we wanted to; we saw it as a point of differentiation. The telemedicine industry is full of local companies, with very, very few international players. Even the world’s biggest telemedicine company, which presents itself as international, actually operates from a bunch of hubs and doesn’t have a local presence in all the markets as we do. So who you associate with, both in terms of your colleagues and your clients, can also be a really key driver internationally.
Nice, nice. It pretty much personifies what we call “think global”: think global as you do your business. That’s great. But what about the compliance and integrations for different countries? Was it a nightmare, or is there something you can advise other founders on?
Yeah, that’s a really good point, and I should have mentioned it without you prompting, because it’s a really key element as well. Particularly if you’re operating in a regulated space like we are, choose your product wisely. Particularly in the early days, we focused on the elements of what we’re doing that are the most universal. One of the big challenges health tech companies in the US have, for example, is that very often they’re solving a problem that doesn’t even exist in other parts of the world. It’s a uniquely American problem, and the US healthcare system is full of those. That’s of course true in other countries as well: there are whole concepts, whole ways of working, that are unique to one country or one region in the healthcare space.
So we really focused initially on a service that was universal, which was text advice, and that allowed us to roll out a service globally that was a very light touch from a regulatory standpoint. Working with local doctors in every market also gave us a significant advantage, because generally the regulations are really around protecting the power of local doctors, so if you’re not crossing borders there, that is very helpful. From that initial service, which was universal to all healthcare systems, we’ve expanded market by market into more integrated, deeper services, for example e-prescriptions, which require integrations with national prescribing systems, things like that. And of course, as you grow, you’re also able to put in place the regulatory and legal reviews and all these more expensive, slower models.
So as much as possible, choose the elements of your service that are universal, that are a bit lighter touch and don’t come with as much regulatory burden, and then expand from there. I think this is an important principle for tech startups generally: don’t get ahead of yourself. Being right on time with everything is really critical. You don’t want to build something that people aren’t ready to use or ready to pay for. At the same time, you don’t want to be too late with things, particularly in the regulated environment we’re working in. So that would be my biggest piece of advice. It certainly worked for us, and it allowed us to be in the 40 countries and 26 languages that we operate in.
Great, that’s great. I can imagine it’s a lot of action every day, but it’s great that you pulled it off. That kind of success is hard to get, so well deserved.
Thank you.
So, one last question, and I’d like to keep this one interesting. I saw one of your stints was in Tanzania before this. What was that about? It did not sound like healthcare.
Are you asking because you have an interest in Tanzania yourself?
I’m always interested, in my life, no doubt.
Okay, I thought maybe you may have been there. Yeah, so that was just a bit of a for-fun project I did with my brother. I mentioned before that I had experience working in sub-Saharan Africa. I had actually started a mobile opinion polling business in Uganda using USSD (Unstructured Supplementary Service Data) technology, for anyone listening who knows their old-school mobile phone deep tech. That was a really fascinating project. To some degree we were looking for a country where there was the right balance in terms of the electoral process, where we could deploy opinion polls. One of the issues with an electoral system is that you’ve got the moment of the election, but what about between elections? How do you give a voice to public opinion in those moments? That’s really what that project was based on. We had a partnership with the biggest newspaper in Uganda, and that got me to the region.
My brother was there for business reasons as well. He’s a funds lawyer with Clifford Chance and was doing some work in the region. We both just fell in love with the region, started looking for a good excuse to spend time there, and started a safari business. It was just a hobby for a few years, but it kept us engaged with the region and gave us an excuse to go down there. I ended up getting involved in a few other projects in the region as well, and I’m still deeply engaged. I’ve got a lot of love for a lot of parts of the world, but East Africa in particular is close to my heart.
Great, great. Glad to know about that part of your work. Thank you, this was an excellent talk. I really enjoyed this conversation, Kim, and thank you so much for sharing your insights. We wish you all the best in your endeavors.
Thank you so much, Ayush. Take care.
Thank you for joining us on the HealthTech with Purpose podcast. Before you leave, make sure to like and subscribe on Spotify, Apple and YouTube. And if you would like to see someone on this podcast, do refer them to us; my contact details are in the description. Before I leave, I wish you: stay healthy, stay curious, and keep building.
At the time of recording (published March 2024), Kim-Fredrik Schneider was CEO and co-founder of Abi Global Health, which he started in 2016 with Dr. Victor Vicens to make professional healthcare radically accessible. By his account Abi delivered on-demand, AI-supported consultations with real doctors through clients’ apps, websites and messaging channels, operating in 40 countries and 26 languages. Before Abi he was Executive Vice President at Sermo, a global social network for doctors, where he led about 200 people across eight offices selling services into the pharmaceutical industry. He also started a mobile opinion polling business in Uganda and a safari business in Tanzania. He was born in San Francisco with American and Swedish citizenship. He remains CEO of Abi Global Health, which now describes its reach as more than 42 countries and 27 languages.
Building a virtual care product that has to live inside other people’s apps and records? Tell us where it needs to plug in, and we’ll show you how we’d build it.
Partner with us to design, build, and scale digital solutions that drive better outcomes.
Global Tech Teams LLC, 525 Washington Blvd, Industrious at Newport Tower, Jersey City, NJ 07310, United States.
Let’s discuss your goals, workflows, and next steps in a focused consultation call.